$13.2M
+$13.2M this year1 filing since 2026 · latest Equity filed
Hyperion Surgical is a medical technology company developing robotic and AI-enabled systems for vascular access and interventional procedures. Its lead product, the Ivy robotic vascular access platform, automates peripheral IV catheterization by combining continuous ultrasound imaging, AI vessel recognition, robotic probe stabilization, and robotic needle and catheter insertion. In 2025 the company completed a first-in-human study that it describes as the world's first robotic-assisted IV catheterization, and it plans an FDA submission and further clinical evaluation ahead of commercialization. The company was founded by neurosurgeon Dr. Eric Peterson and operates from South Florida.
What sets it apart
Ivy replaces the two-handed, operator-dependent technique of ultrasound-guided IV placement with a semi-autonomous no-touch procedure, targeting the difficult-access patients where manual first-stick failure rates can exceed 50%.
A robotic, AI-guided system that performs peripheral intravenous catheterization under continuous ultrasound visualization.
